Literature DB >> 19485893

Regulation of the sodium-phosphate cotransporter Pit-1 and its role in vascular calcification.

Magdalena Gonzalez1, Rafael Martínez, Cristián Amador, Luis Michea.   

Abstract

Vascular calcification is caused by the deposition of basic calcium phosphate crystals in blood vessels, myocardium, and/or cardiac valves. Calcification decreases artery wall compliance, and arterial calcification is associated to mortality in hyperphosphatemic renal failure and diabetes mellitus. The calcification of the tunica media characterizes the arteriosclerosis observed with age, diabetes and end stage-renal disease, and it can develop independently from intima calcification. As part of the vascular calcification mechanism, vascular smooth muscle cells (VSMC) experience a transition from a contractile to an osteochondrogenic phenotype and a sequence of molecular events that are typical of endochondral ossification. The current evidence indicates a key role of increased phosphate uptake by VSMC for calcification, which supplies the substrate for hydroxyapatite formation and could trigger or potentiate VSMC transdiferentiation. The present review analyzes the sodium-phosphate cotransporter Pit-1, which is implicated in calcification. On the basis of the available data obtained in the study of vascular and osteoblastic experimental models, we discuss potential regulatory mechanisms that could lead to increased sodium-dependent phosphate uptake in vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19485893     DOI: 10.2174/157016109789043946

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  2 in total

1.  Association between a novel mutation in SLC20A2 and familial idiopathic basal ganglia calcification.

Authors:  Yang Zhang; Xianan Guo; Anhua Wu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

2.  Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation.

Authors:  Setareh Orth-Alampour; Nathalie Gayrard; Silvia Salem; Àngel Argilés; Joachim Jankowski; Shruti Bhargava; Vera Jankowski; Bernard Jover; Cécile Notarnicola; Heidi Noels; Emiel P C van der Vorst; Christoph Kuppe; Michael Wolf; Claudia Goettsch; Wendy Theelen; Heike Bruck; Danilo Fliser; Joseph Loscalzo; Zhuojun Wu; Nikolaus Marx; Walter Zidek
Journal:  Basic Res Cardiol       Date:  2021-10-13       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.